Release Date: 06/10/10 11:58 Summary: Major Breakthrough on Sales Price Sensitive: Yes Download Document 200.09KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%